The manufacture of infusion solutions, or as they are popularly called "droppers," was launched in 2015. The company invested EUR 20 million. According to
Dmytro Shymkiv, the project should pay off in 7 years – by 2023.
Infusion manufacture is one of the most innovative areas for Darnitsa.
In fact, infusions are the usual injection solutions in ampoules, but are available in large volume packaging – from 100 ml and more. The main drugs in Darnitsa's portfolio are sodium chloride and glucose.
What is innovative?
Darnitsa was the first in the Ukrainian market to start manufacturing infusions in polypropylene bottles.
"As a rule, several types of primary packaging are used in the manufacture of infusion: polyethylene, polypropylene or glass. Glass is the most common", says manufacture director Liudmyla Denesiuk. – We decided to use polypropylene. It does not get deformed, does not break and survives regulated sterilization methods – 121°C for 15 minutes. The polythene cannot survive them, and the glass can break".